ACRS - Aclaris Therapeutics, Inc.
IEX Last Trade
3.01
0.065 2.159%
Share volume: 13,758
Last Updated: Thu 26 Dec 2024 08:29:10 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$2.94
0.07
2.21%
Summary score
20%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.34%
Return on assets
-10.22%
Return on sales
-836.3%
Return on invested capital
-234.15%
Total debt ratio
25.65%
Debt ratio change over timeo
-1.45%
Current Ratio
8.79%
Quick Ratio
9.11%
Cash Position Ratio
8.16%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.01%
Return on assets
-11.38%
Return on sales
-700.88%
Return on invested capital
-43.72%
Total debt ratio
22.73%
Debt ratio change over timeo
-2.54%
Current Ratio
5.31%
Quick Ratio
5.31%
Cash Position Ratio
4.81%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-11.93%
Return on assets
-9.27%
Return on sales
-672.69%
Return on invested capital
-90.85%
Total debt ratio
18.41%
Debt ratio change over time
-5.64%
Current Ratio
6.74%
Quick Ratio
6.74%
Cash Position Ratio
6.38%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-72.16%
Return on assets
-78.13%
Return on sales
1753.4%
Return on invested capital
107.63%
Total debt ratio
-144.95%
Debt ratio change over time
-1.45%
Current Ratio
-18.43%
Quick Ratio
-19.7%
Cash Position Ratio
-17.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACRS | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -15.34% | 18.83% | 17.34% | 7.6% |
| Return on assets | -10.22% | 4.16% | 8.21% | 3.22% |
| Return on sales | -836.3% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | -234.15% | 9.79% | -219.55% | 7.46% |
| Profitability | 0% | 80% | 73% | 54% |
| Total debt ratio | 25.65% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -1.45% | -4.38% | -0.73% | -33.74% |
| Dept financing | 8% | 25% | 42% | 18% |
| Current Ratio | 5.31% | 1.12% | 0% | 1.16% |
| Quick Ratio | 5.31% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 4.81% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 7% | 7% | 8% |
| Short-term ratios | ACRS | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -12.01% | 13.31% | 0% | 13.48% |
| Return on assets | -11.38% | 4.72% | 0% | 3.05% |
| Return on sales | -700.88% | 31.4% | 0% | 25.56% |
| Return on invested capital | -43.72% | 10.68% | 0% | 13.96% |
| Profitability | 0% | 94% | 0% | 87% |
| Total debt ratio | 22.73% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -2.54% | -41.82% | 0% | 7.13% |
| Dept financing | 7% | 25% | 0% | 43% |
| Current Ratio | 5.31% | 1.12% | 0% | 1.16% |
| Quick Ratio | 5.31% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 4.81% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 10% | 0% | 12% |